Rapidpoint Enox test regulatory update

PHAR and partner Aventis S.A. (AVE, Strasbourg, France) submitted a 510(k) to the FDA for PHAR's Rapidpoint Enox test to analyze blood levels of AVE's Lovenox enoxaparin. Lovenox is a low molecular ...